Personalized oncology: Recent advances and future challenges

Metabolism: Clinical and Experimental

Volumn 62, Issue SUPPL.1, 2013, Pages

  Kalia, Madhu ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Biomarkers; Cancer; Predictive markers; Tumor markers

Indexed keywords

B RAF KINASE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; GEFITINIB; GLUCURONOSYLTRANSFERASE 1A1; IRINOTECAN; K RAS PROTEIN; MERCAPTOPURINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PANITUMUMAB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TAMOXIFEN; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PREVENTION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; GENETIC SCREENING; GLIOMA; HUMAN; INTERVENTIONAL RADIOLOGY; LUNG NON SMALL CELL CANCER; MOLECULAR DIAGNOSIS; MOLECULAR IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 84870526559     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.016     Document Type: Article

References (24)

1. President's Council of Advisors on Science and Technology Priorities for personalized medicine [online] Available from URL: http://www.whitehouse.gov/ files/documents/ostp/PCAST/pcast-report-v2.pdf [Accessed 2011 Feb 18]
2. J. Hoggart Personalized medicine - trends in molecular diagnostics. Exponential growth expected in the next ten years Mol Diagn Ther 15 1 2011 53 55
3. Personalized Medicine Coalition The case for personalized medicine 2006 Personalized Medicine Coalition Washington, DC
4. B. Pasche, and D. Absher Whole-genome sequencing. a step closer to personalized medicine JAMA 305 15 2011 1596 1597
5. M.B. Daly, J.E. Axilbund, and S. Buys National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian J Natl Compr Canc Netw 8 5 2010 562 594
6. R.W. Burt, J.S. Barthel, and K.B. Dunn NCCN. NCCN clinical practice guidelines in oncology: colorectal cancer screening J Natl Compr Canc Netw 8 1 2010 8 61
7. M.R. O'Donnell, C.H. Abboud, and J. Altman Acute myeloid leukemia J Natl Compr Canc Netw 9 3 2011 280 317
8. H. Yaziji, L.C. Goldstein, and T.S. Barry HER-2 testing in breast cancer using parallel tissue-based methods JAMA 291 16 2004 1972 1977
9. W. De Roock, D.J. Jonker, and F. Di Nicoantonio Association of KRAS p. G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab JAMA 304 16 2010 1812 1820
10. C. Kim, and S. Paik Gene-expression-based prognostic assays for breast cancer Nat Rev Clin Oncol 7 6 2010 340 347
11. Q. Tian, N.D. Price, and L. Hood Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine J Intern Med 271 2012 111 121
12. R.A. Walgren, M.A. Meucci, and H.L. McLeod Pharmacogenomics discovery approaches: will the real genes please stand up? J Clin Oncol 23 2005 7342 7349
13. M.J. Duffy, N. O'Donovan, and J. Crown Use of molecular markers for predicting therapy response in cancer patients Cancer Treat Rev 37 2011 151 159
14. R.S. Huang, and M.J. Ratain Pharmacogenetics and pharmacogenomics of anticancer agents CA Cancer J Clin 59 2009 42 55
15. C.L. Sawyers The cancer biomarker problem Nature 452 2008 548 552
16. H. Hricak Oncologic imaging: a guiding hand of personalized cancer care Radiology 259 3 2011 633 640
17. B.N. Hellquist, S.W. Duffy, and S. Abdsaleh Effectiveness of population-based service screening with mammography for women ages 40-49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort Cancer 117 4 2010 714 722
18. S. Basu Personalized versus evidence-based medicine with PET-based imaging Nat Rev Clin Oncol 7 2010 665 668
19. P.J. Stephen, D.J. McBride, and M.L. Lin Complex landscapes of somatic rearrangement in human breast cancer genomes Nature 462 2009 1005 1010
20. W. Pao, and J. Chemielecki Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer Nat Rev Cancer 10 2010 760 774
21. P.G. Casali, J.Y. Blay on behalf of the ESMO/CONTICANET/EURONET Consensus Panel of Experts Gastrointestinal stromal tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl 5 2010 v98 102
22. J.-Y. Blay, D. Lacombe, F. Meunier, and R. Stupp Personalized medicine in oncology: questions for the next 20 years Lancet 13 2012 448 449
23. J.S. Ross Cancer biomarkers, companion diagnostics and personalized oncology Biomarkers Med. 5 3 2011 277 279
24. G.S. Ginsburg, and J.J. McCarthy Personalized medicine: revolutionizing drug discovery and patient care Trends Biotechnol 19 2001 491 496